LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Selumetinib | 1.11 | uM | LJP6 | 72 | hr | 868 | 1812 | 3486 | 0.5199 | 0.3608 |
MDA-MB-231 | Sirolimus | 1.11 | uM | LJP6 | 72 | hr | 868 | 2714 | 3486 | 0.7786 | 0.7051 |
MDA-MB-231 | Sorafenib | 1.11 | uM | LJP6 | 72 | hr | 868 | 2640 | 3486 | 0.7572 | 0.6767 |
MDA-MB-231 | SU11274 | 1.11 | uM | LJP5 | 72 | hr | 868 | 3394 | 3486 | 0.9735 | 0.9647 |
MDA-MB-231 | Fedratinib | 1.11 | uM | LJP5 | 72 | hr | 868 | 2260 | 3486 | 0.6483 | 0.5317 |
MDA-MB-231 | TGX221 | 1.11 | uM | LJP5 | 72 | hr | 868 | 2919 | 3486 | 0.8373 | 0.7833 |
MDA-MB-231 | Torin1 | 1.11 | uM | LJP6 | 72 | hr | 868 | 1323 | 3486 | 0.3795 | 0.1737 |
MDA-MB-231 | Torin2 | 1.11 | uM | LJP5 | 72 | hr | 868 | 1038 | 3486 | 0.2977 | 0.0649 |
MDA-MB-231 | Tozasertib | 1.11 | uM | LJP5 | 72 | hr | 868 | 1078 | 3486 | 0.3093 | 0.0803 |
MDA-MB-231 | Trametinib | 1.11 | uM | LJP5 | 72 | hr | 868 | 1147 | 3486 | 0.3290 | 0.1065 |
MDA-MB-231 | TWS119 | 1.11 | uM | LJP5 | 72 | hr | 868 | 2921 | 3486 | 0.8378 | 0.7841 |
MDA-MB-231 | Vemurafenib | 1.11 | uM | LJP5 | 72 | hr | 868 | 2853 | 3486 | 0.8183 | 0.7581 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP5 | 72 | hr | 868 | 936 | 3486 | 0.2687 | 0.0262 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP6 | 72 | hr | 868 | 807 | 3486 | 0.2317 | -0.0231 |
MDA-MB-231 | WYE-125132 | 1.11 | uM | LJP6 | 72 | hr | 868 | 1776 | 3486 | 0.5096 | 0.3470 |
MDA-MB-231 | WZ3105 | 1.11 | uM | LJP5 | 72 | hr | 868 | 722 | 3486 | 0.2071 | -0.0558 |
MDA-MB-231 | XMD11-50 | 1.11 | uM | LJP6 | 72 | hr | 868 | 1436 | 3486 | 0.4119 | 0.2169 |
MDA-MB-231 | Y39983 | 1.11 | uM | LJP6 | 72 | hr | 868 | 2552 | 3486 | 0.7322 | 0.6434 |
MDA-MB-231 | YM 201636 | 1.11 | uM | LJP5 | 72 | hr | 868 | 2841 | 3486 | 0.8151 | 0.7538 |
MDA-MB-231 | ZSTK474 | 1.11 | uM | LJP6 | 72 | hr | 868 | 2454 | 3486 | 0.7040 | 0.6058 |
MDA-MB-231 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 868 | 2182 | 3486 | 0.6260 | 0.5019 |
MDA-MB-231 | Sigma A6730 | 3.33 | uM | LJP5 | 72 | hr | 868 | 2960 | 3486 | 0.8490 | 0.7990 |
MDA-MB-231 | Alvocidib | 3.33 | uM | LJP6 | 72 | hr | 868 | 612 | 3486 | 0.1755 | -0.0978 |
MDA-MB-231 | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 868 | 588 | 3486 | 0.1689 | -0.1067 |
MDA-MB-231 | AZD 5438 | 3.33 | uM | LJP6 | 72 | hr | 868 | 793 | 3486 | 0.2277 | -0.0284 |